Predicted Trait | |
Reported Trait | Systolic blood pressure |
Mapped Trait(s) | systolic blood pressure (EFO_0006335) |
Score Construction | |
PGS Name | SBP-PRS |
Development Method | |
Name | Genome-wide significant variants |
Parameters | p<5E-08 |
Variants | |
Original Genome Build | NR |
Number of Variants | 425 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000303 |
Citation (link to publication) | Groenland EH et al. Atherosclerosis (2022) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST006628 Europe PMC: 30224653 |
757,601 individuals | European | NR |
GWAS Catalog: GCST006228 Europe PMC: 27618448 |
120,473 individuals | European | NR |
GWAS Catalog: GCST006228 Europe PMC: 27618448 |
21,503 individuals | African American or Afro-Caribbean | NR |
GWAS Catalog: GCST006228 Europe PMC: 27618448 |
4,586 individuals | Hispanic or Latin American | NR |
GWAS Catalog: GCST007267 Europe PMC: 30578418 |
365,998 individuals | European | MVP, UKB |
GWAS Catalog: GCST007267 Europe PMC: 30578418 |
63,490 individuals | African unspecified | MVP, UKB |
GWAS Catalog: GCST007267 Europe PMC: 30578418 |
22,802 individuals | Hispanic or Latin American | MVP, UKB |
GWAS Catalog: GCST007267 Europe PMC: 30578418 |
4,792 individuals | Asian unspecified | MVP, UKB |
GWAS Catalog: GCST007267 Europe PMC: 30578418 |
2,695 individuals | Native American | MVP, UKB |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM012945 | PSS009627| European Ancestry| 4,416 individuals |
PGP000303 | Groenland EH et al. Atherosclerosis (2022) |
Reported Trait: Systolic blood pressure | β: 3.19 [2.6, 3.78] | — | — | Age, sex, the first 5 principal components, BMI, T2DM, smoking, alcohol use, LDL-cholesterol, eGFR, triglycerides, antihypertensive medication | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS009627 | — | — | 4,416 individuals, 75.0 % Male samples |
European | — | UCC-SMART | UCC-SMART |